Xiamen Kingdomway Group Company

SZSE:002626 Rapport sur les actions

Capitalisation boursière : CN¥8.8b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Xiamen Kingdomway Group Croissance future

Future contrôle des critères 3/6

Xiamen Kingdomway Group is forecast to grow earnings and revenue by 30.1% and 8.5% per annum respectively. EPS is expected to grow by 30% per annum. Return on equity is forecast to be 11.7% in 3 years.

Informations clés

30.1%

Taux de croissance des bénéfices

30.0%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices18.8%
Taux de croissance des recettes8.5%
Rendement futur des capitaux propres11.7%
Couverture par les analystes

Low

Dernière mise à jour13 Jun 2024

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Xiamen Kingdomway Group (SZSE:002626) Has Affirmed Its Dividend Of CN¥0.20

May 31
Xiamen Kingdomway Group (SZSE:002626) Has Affirmed Its Dividend Of CN¥0.20

Is Xiamen Kingdomway Group (SZSE:002626) A Risky Investment?

May 28
Is Xiamen Kingdomway Group (SZSE:002626) A Risky Investment?

What Xiamen Kingdomway Group Company's (SZSE:002626) P/E Is Not Telling You

Apr 30
What Xiamen Kingdomway Group Company's (SZSE:002626) P/E Is Not Telling You

Is Xiamen Kingdomway Group (SZSE:002626) Using Too Much Debt?

Feb 28
Is Xiamen Kingdomway Group (SZSE:002626) Using Too Much Debt?

Prévisions de croissance des bénéfices et des revenus

SZSE:002626 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,832638N/A7801
12/31/20253,526508N/A6501
12/31/20243,192387N/A5801
3/31/20243,055261185427N/A
12/31/20233,103277407659N/A
9/30/20233,025152563786N/A
6/30/20232,997167679870N/A
3/31/20233,058224628822N/A
1/1/20233,009257533695N/A
9/30/20223,216472428637N/A
6/30/20223,404556369705N/A
3/31/20223,456609478801N/A
12/31/20213,616789503847N/A
9/30/20213,640830528863N/A
6/30/20213,673971664866N/A
3/31/20213,6051,042673949N/A
12/31/20203,504959718968N/A
9/30/20203,4647177521,024N/A
6/30/20203,2465757961,046N/A
3/31/20203,320537707894N/A
12/31/20193,192451743918N/A
9/30/20193,090564848957N/A
6/30/20193,096567859910N/A
3/31/20192,789480835882N/A
12/31/20182,873687808887N/A
9/30/20182,792885640730N/A
6/30/20182,510815552709N/A
3/31/20182,419746537659N/A
12/31/20172,085474N/A494N/A
9/30/20171,836345N/A482N/A
6/30/20171,762319N/A405N/A
3/31/20171,704318N/A367N/A
12/31/20161,663300N/A374N/A
9/30/20161,570196N/A299N/A
6/30/20161,464157N/A189N/A
3/31/20161,330119N/A135N/A
12/31/20151,204113N/A82N/A
9/30/20151,078159N/A65N/A
6/30/2015981178N/A103N/A
3/31/2015899192N/A142N/A
12/31/2014838195N/A161N/A
9/30/2014783184N/A173N/A
6/30/2014759168N/A180N/A
3/31/2014703129N/A192N/A
12/31/2013670102N/A202N/A
9/30/201365782N/A180N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 002626's forecast earnings growth (30.1% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 002626's earnings (30.1% per year) are forecast to grow faster than the CN market (21.9% per year).

Croissance élevée des bénéfices: 002626's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 002626's revenue (8.5% per year) is forecast to grow slower than the CN market (13.4% per year).

Croissance élevée des revenus: 002626's revenue (8.5% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 002626's Return on Equity is forecast to be low in 3 years time (11.7%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y